Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design, synthesis and biological evaluation of symmetric thiadiazole carboxamide derivative as glutaminase inhibitor.

Bioorganic & medicinal chemistry letters·2026
Same author

Clinical Outcomes of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome in Patients with Traumatic Brain Injury or Spontaneous Intracerebral and Subarachnoid Hemorrhages: A Retrospective PILOT Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Ultrathin Iridium Nanosheets on Titanium Oxide for High-Efficiency and Durable Proton Exchange Membrane Water Electrolysis.

ACS nano·2025
Same author

Atomic-scale 3D structural dynamics and functional degradation of Pt alloy nanocatalysts during the oxygen reduction reaction.

Nature communications·2025
Same author

High-coverage allele-resolved single-cell DNA methylation profiling reveals cell lineage, X-inactivation state, and replication dynamics.

Nature communications·2025
Same author

Discovery of benzimidazole-2-amide BNZ-111 as new tubulin inhibitor.

Bioorganic & medicinal chemistry letters·2024

Related Experiment Video

Updated: Apr 16, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

653

Plexiform neurofibroma treated with pharmacopuncture.

Chungsan Lim1, Kirok Kwon2, Kwangho Lee3

  • 1Department of Oriental Medicine, Seil Hospital, Wonju, Korea.

Journal of Pharmacopuncture
|March 18, 2015
PubMed
Summary

Sweet bee venom (SBV) and mountain ginseng pharmacopuncture (MGP) showed potential in managing plexiform neurofibromas (PNFs). This case study suggests these treatments may help slow tumor growth and improve patient well-being.

Keywords:
mountain ginseng pharmacopunctureneurofibromaneurofibromatosis type 1pharmacopunctureplexiform neurofibromasweet bee venom

More Related Videos

Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
08:20

Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain

Published on: June 30, 2023

3.0K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

3.3K

Related Experiment Videos

Last Updated: Apr 16, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas
03:53

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

653
Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
08:20

Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain

Published on: June 30, 2023

3.0K
Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
03:53

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management

Published on: March 15, 2024

3.3K

Area of Science:

  • Integrative oncology
  • Pharmacological research
  • Tumor biology

Background:

  • Plexiform neurofibromas (PNFs) associated with neurofibromatosis type 1 (NF1) present significant clinical challenges.
  • Surgical interventions for PNFs often result in continued tumor growth and recurrence.
  • Novel therapeutic strategies are needed to manage NF1-related PNFs.

Observation:

  • A 16-year-old female with a history of NF1 and multiple surgeries for pelvic PNFs experienced persistent tumor growth.
  • The patient received intra-subcutaneous sweet bee venom (SBV) and intravenous mountain ginseng pharmacopuncture (MGP) bi-monthly for four years.
  • Pre-treatment observation indicated rapid and steady growth of PNFs.

Findings:

  • Following SBV and MGP treatment, the growth rate of PNFs significantly decreased, nearing cessation.
  • The patient reported a reduction in hip joint pain and an overall improvement in general condition.
  • Tumor size and associated symptoms showed positive response to the combined treatment.

Implications:

  • SBV and MGP may offer a complementary therapeutic approach for managing plexiform neurofibromas in NF1 patients.
  • Further research is warranted to elucidate the mechanisms of action and efficacy of SBV and MGP in neurofibroma treatment.
  • This case highlights the potential of integrative medicine in addressing complex oncological conditions.